Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to -$149.1 million.

  • Caribou Biosciences' Income from Continuing Operations rose 23.11% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year increase of 3.88%. This contributed to the annual value of -$149.1 million for FY2024, which is 46.08% down from last year.
  • According to the latest figures from FY2024, Caribou Biosciences' Income from Continuing Operations is -$149.1 million, which was down 46.08% from -$102.1 million recorded in FY2023.
  • Caribou Biosciences' Income from Continuing Operations' 5-year high stood at -$34.3 million during FY2020, with a 5-year trough of -$149.1 million in FY2024.
  • For the 3-year period, Caribou Biosciences' Income from Continuing Operations averaged around -$116.9 million, with its median value being -$102.1 million (2023).
  • Data for Caribou Biosciences' Income from Continuing Operations shows a maximum YoY tumbled of 95.07% (in 2021) over the last 5 years.
  • Over the past 5 years, Caribou Biosciences' Income from Continuing Operations (Yearly) stood at -$34.3 million in 2020, then slumped by 95.07% to -$66.9 million in 2021, then plummeted by 48.56% to -$99.4 million in 2022, then fell by 2.66% to -$102.1 million in 2023, then slumped by 46.08% to -$149.1 million in 2024.